Kidney Dosimetry in <sup>177</sup>Lu and <sup>90</sup>Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors

<table>Examples of observed pharmacokinetic behaviour: with-accumulation (blue line, pt no. 45), single-slope clearance (red line, pt no. 43), two-slope clearance (violet line, pt no. 38).</table>

BioMed Research International

fig1

Figure 1

Figure 1: Kidney Dosimetry in <sup>177</sup>Lu and <sup>90</sup>Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors 

Figure 1 | Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors 